Skip to main content
. 2012 Dec 18;12:148. doi: 10.1186/1472-6947-12-148

Table 3.

Performance evaluation for Alzheimer’s disease

Selection Rank Recall Precision F-score
Baseline: Genes / Proteins
60
0.10
0.92
0.17
 
230
0.30
0.73
0.42
 
469
0.50
0.61
0.55
Maximal F-score
728
0.67
0.52
0.59
Baseline + Clinical Management
61
0.10
0.90
0.17
 
226
0.30
0.75
0.42
 
465
0.50
0.61
0.55
Maximal F-score
682
0.65
0.54
0.59
Baseline + Evidence Marker
62
0.10
0.89
0.17
 
225
0.30
0.75
0.42
 
464
0.50
0.61
0.55
Maximal F-score
654
0.62
0.54
0.57
Baseline +Prognosis
63
0.10
0.87
0.17
 
247
0.30
0.68
0.41
 
541
0.50
0.52
0.51
Maximal F-score
740
0.61
0.47
0.53
Baseline + Diagnostics
64
0.10
0.86
0.17
 
237
0.30
0.71
0.42
 
494
0.50
0.57
0.53
Maximal F-score
520
0.52
0.57
0.54
Baseline + Statistics
64
0.10
0.86
0.17
 
227
0.30
0.74
0.42
 
678
0.50
0.42
0.45
Maximal F-score
377
0.41
0.62
0.49
Baseline + Clinical Management + Evidence Marker
60
0.10
0.92
0.17
 
224
0.30
0.75
0.42
 
451
0.50
0.63
0.56
Maximal F-score
555
0.57
0.59
0.58
Baseline + Clinical Management + Evidence Marker + Prognosis
61
0.10
0.90
0.17
 
230
0.30
0.73
0.42
 
568
0.50
0.50
0.50
Maximal F-score 479 0.47 0.56 0.51

Genes were ranked based on frequency and evaluated against the Alzheimer’s gold standard. For the different selections recall, precision, F-score and rank has been estimated for 10, 30, and 50% recall. In addition the maximal recall has been estimated.